Immunic, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-44.7M | $38.2M |
| FY2014 | — | $97.6M | $102.2M |
| FY2015 | — | $82.3M | $83.4M |
| FY2016 | — | $58.4M | $60.0M |
| FY2017 | — | $-13.3M | $56.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-44.7M | $38.2M |
| FY2014 | — | $97.6M | $102.2M |
| FY2015 | — | $82.3M | $83.4M |
| FY2016 | — | $58.4M | $60.0M |
| FY2017 | — | $-13.3M | $56.9M |